Objective Analysis of Caesarean Scar Pregnancy

Caesarean Scar Pregnancy Clinical Trial

Official title:

The Predictive Value of an Ultrasound Quantitative Scoring System for Treatment Method Selection in Patients With Caesarean Scar Pregnancy: A Single-Centre Retrospective Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06276790
• Other study ID #: ChengdeCentralHospital
• Status: Completed
• Start date: January 18, 2019
• Est. completion date: December 25, 2022

Study information

• Verified date: February 2024
• Source: Chengde Central Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study uses a systematic scoring method combined with clinical and ultrasound data to comprehensively evaluate patient conditions and explore the guiding value of the ultrasound quantitative scoring system for selecting the surgical approach for caesarean scar pregnancy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 117
• Est. completion date: December 25, 2022
• Est. primary completion date: December 23, 2022
• Gender: Female
• Age group: 20 Years and older

Eligibility

Inclusion Criteria:

• history of at least one previous caesarean section

• symptoms suggestive of caesarean scar pregnancy, such as unexplained abnormal vaginal bleeding, abdominal pain, cervical pain or abnormal uterine activity during pregnancy

• amenorrhea =84 days

• ultrasound examination suggesting a single gestational sac with intact morphology

• stable maternal vital signs

Exclusion Criteria:

• mass-type caesarean scar pregnancy

• previous medication or surgical treatment before ultrasound examination

• haemodynamically unstable patients

• patients with surgical contraindications

• incomplete or lost follow-up clinical data

• patients with severe medical conditions such as hypertension, diabetes, hyperthyroidism and haemophilia

Related Conditions & MeSH terms

• Caesarean Scar Pregnancy

Intervention

Procedure:
• ultrasound-guided/hysteroscopic curettage
ultrasound-guided/hysteroscopic curettage
• Procedure/Surgery: laparoscopic removal of the pregnancy lesion
laparoscopic removal of the pregnancy lesion

Locations

Country	Name	City	State
China	Chengde Central Hospital	Chengde

Sponsors (1)

Lead Sponsor	Collaborator
Chengde Central Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	intraoperative blood loss	The patient's blood loss during surgery. Check the blood volume in ml of the aspirator reservoir.	during surgery
Primary	length of hospital stay	Number of days the patient was hospitalized. Discharge assessment: vital signs stable, no abdominal pain, no active bleeding.	Within 1 week
Primary	serum ß-HCG levels	The time taken for serum ß-HCG levels to return to normal	Within 2 weeks after the operation